XML 22 R12.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCKHOLDERS' EQUITY
6 Months Ended
Jun. 30, 2017
STOCKHOLDERS' EQUITY [Abstract]  
STOCKHOLDERS' EQUITY
5.
STOCKHOLDERS’ EQUITY

Restricted Stock

The Company has two stock incentive plans:  a Long-Term Incentive Plan (the “LTIP”) and a Non-Employee Directors Restricted Stock Plan (the “Non-Employee Directors Plan”).

Under the LTIP, certain employees received awards of restricted shares of common stock based on service and performance.  The number of shares granted to each employee is based on the fair market value of a share of common stock on the date of grant.
 
On May 13, 2016 and January 16, 2017, performance-based restricted shares were granted to certain employees of the Company, which vest on March 15, 2017 and March 15, 2018 based upon the attainment of a financial responsibility ratio during each fiscal year ending December 31, 2016 and 2017.  There is no restriction on the right to vote or the right to receive dividends with respect to any of these restricted shares.

On June 2, 2014 and December 18, 2014, performance-based restricted shares were granted to certain employees of the Company, which vest over three years based upon the attainment of (i) a specified operating income margin during any one or more of the fiscal years in the period beginning January 1, 2015 and ending December 31, 2017 and (ii) the attainment of earnings before interest, taxes, depreciation and amortization targets during each of the fiscal years ended December 31, 2015 through 2017.  There is no restriction on the right to vote or the right to receive dividends with respect to any of these restricted shares.

Pursuant to the Non-Employee Directors Plan, each non-employee director of the Company receives an annual award of restricted shares of common stock on the date of the Company’s annual meeting of shareholders.  The number of shares granted to each non-employee director is based on the fair market value of a share of common stock on that date.  The restricted shares vest on the first anniversary of the grant date.  There is no vesting period on the right to vote or the right to receive dividends with respect to these restricted shares.

For the six months ended June 30, 2017 and 2016, the Company completed a net share settlement for 184,231 and 38,389 restricted shares, respectively, on behalf of certain employees that participate in the LTIP upon the vesting of the restricted shares pursuant to the terms of the LTIP.  The net share settlement was in connection with income taxes incurred on restricted shares that vested and were transferred to the employees during 2017 and/or 2016, creating taxable income for the employees.   At the employees’ request, the Company will pay these taxes on behalf of the employees in exchange for the employees returning an equivalent value of restricted shares to the Company.  These transactions resulted in a decrease of $0.4 million and $0.1 million for each of the six months ended June 30, 2017 and 2016, respectively, to equity on the condensed consolidated balance sheets as the cash payment of the taxes effectively was a repurchase of the restricted shares granted in previous years.

The following is a summary of transactions pertaining to restricted stock:

  
Shares
  
Weighted
Average Grant
Date Fair Value
Per Share
 
Nonvested restricted stock outstanding at December 31, 2016
  
1,143,599
  
$
1.89
 
Granted
  
181,208
   
2.58
 
Canceled
  
(52,398
)
  
5.63
 
Vested
  
(650,130
)
  
1.74
 
         
Nonvested restricted stock outstanding at June 30, 2017
  
622,279
   
1.92
 

The restricted stock expense for the three months ended June 30, 2017 and 2016 was $0.3 million and $0.3 million, respectively.  The restricted stock expense for the six months ended June 30, 2017 and 2016 was $0.7 million and $0.7 million, respectively.  The unrecognized restricted stock expense as of June 30, 2017 and December 31, 2016 was $0.9 million and $1.5 million, respectively.  As of June 30, 2017, outstanding restricted shares under the LTIP had aggregate intrinsic value of $1.9 million.
 
Stock Options

The fair value of the stock options used to compute stock-based compensation is the estimated present value at the date of grant using the Black-Scholes option pricing model.  The following is a summary of transactions pertaining to stock options:

  
Shares
  
Weighted
Average
Exercise Price
Per Share
 
Weighted
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic Value
(in thousands)
 
Outstanding at December 31, 2016
  
218,167
  
$
12.11
 
 3.33 years
 
$
-
 
Canceled
  
(47,500
)
  
12.37
    
-
 
              
Outstanding at June 30, 2017
  
170,667
   
12.04
 
 3.49 years
  
-
 
              
Vested or expected to vest
  
170,667
   
12.04
 
 3.49 years
  
-
 
              
Exercisable as of June 30, 2017
  
170,667
   
12.04
 
 3.49 years
  
-
 

As of June 30, 2017, there was no unrecognized pre-tax compensation expense.

The following table presents a summary of stock options outstanding:

   
At June 30, 2017
 
   
Stock Options Outstanding
  
Stock Options Exercisable
 
Range of Exercise Prices
  
Shares
  
Contractual
Weighted
Average Life
(years)
  
Weighted
Average Price
  
Shares
  
Weighted
Average Exercise
Price
 
$
4.00-$13.99
   
122,667
   
3.75
  
$
8.77
   
122,667
  
$
8.77
 
$
14.00-$19.99
   
17,000
   
2.34
   
19.98
   
17,000
   
19.98
 
$
20.00-$25.00
   
31,000
   
3.10
   
20.62
   
31,000
   
20.62
 
                       
     
170,667
   
3.49
   
12.04
   
170,667
   
12.04